Cargando…
Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
BACKGROUND: Low bone mineral density (BMD) is commonly observed in people living with HIV (PLWH), however the cause for this BMD loss remains unclear. Sclerostin, a bone-derived antagonist to the Wnt/β-catenin-pathway, suppresses bone remodeling and is positively associated with BMD. The goal of the...
Autores principales: | Ross, Ryan D., Sharma, Anjali, Shi, Qiuhu, Hoover, Donald R., Weber, Kathleen M., Tien, Phyllis C., French, Audrey L., Al-Harthi, Lena, Yin, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235609/ https://www.ncbi.nlm.nih.gov/pubmed/32455152 http://dx.doi.org/10.1016/j.bonr.2020.100279 |
Ejemplares similares
-
Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and Fractures
por: Zheng, Jie, et al.
Publicado: (2019) -
Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women
por: Dusingize, Jean Claude, et al.
Publicado: (2015) -
Serum Sclerostin Level Is Negatively Associated with Bone Mineral Density in Hemodialysis Patients
por: Lu, Jing-Wun, et al.
Publicado: (2022) -
Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study
por: Sharma, Anjali, et al.
Publicado: (2015) -
Circulating levels of sclerostin are associated with cardiovascular mortality
por: Novo-Rodríguez, Cristina, et al.
Publicado: (2018)